Transplantation of mesenchymal stem cells for prevention of acute myocardial infarction induced heart failure: study protocol of a phase III randomized clinical trial (Prevent-TAHA8).
Armin AttarAhmad MonabatiMohammad MontaseriMassoud VosoughSeyed Ali HosseiniJavad KojouriAlireza Abdi-ArdekaniPeyman IzadpanahNegar AzarpiraGholamreza PouladfarMani RamziPublished in: Trials (2022)
ClinicalTrials.gov NCT05043610 , Registered on 14 September 2021 - retrospectively registered.
Keyphrases
- phase iii
- open label
- double blind
- acute myocardial infarction
- mesenchymal stem cells
- heart failure
- clinical trial
- study protocol
- placebo controlled
- left ventricular
- randomized controlled trial
- phase ii
- high glucose
- diabetic rats
- percutaneous coronary intervention
- umbilical cord
- cell therapy
- bone marrow
- drug induced
- endothelial cells
- oxidative stress
- stem cells
- atrial fibrillation
- cardiac resynchronization therapy
- acute heart failure
- coronary artery disease